rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Perry J. Sternberg

Director

Company insider

Files Form 4 as: Director, Harrow.

In numbers

Trades disclosed
6
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
9 Jun 2022
Last trade
18 Jun 2026
Last filed
22 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
HROW HarrowDirector · Pharmaceuticals · last 18 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
18 Jun 2026filed 22 Jun 2026HROW Harrowoption or derivative · PharmaceuticalsSEC FORM 4 Code A—5,248 at $0.00filing
18 Jun 2026filed 22 Jun 2026HROW Harrowoption or derivative · PharmaceuticalsSEC FORM 4 Code A—5,248 at $0.00filing
20 Jun 2025filed 24 Jun 2025HROW Harrowoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,339 at $0.00filing
14 Jun 2024filed 17 Jun 2024HROW Harrowoption or derivative · PharmaceuticalsSEC FORM 4 Code A—8,347 at $0.00filing
21 Jun 2023filed 23 Jun 2023HROW Harrowoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,744 at $0.00filing
9 Jun 2022filed 10 Jun 2022HROW Harrowoption or derivative · PharmaceuticalsSEC FORM 4 Code A—13,123 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Amir ShojaeiChief Scientific Officer · Chief Scientific Officer at Harrow, filing Form 4 there in the last year
Lauren P. SilvernailDirector · Director at Harrow, filing Form 4 there in the last year
Adrienne L. GravesDirector · Director at Harrow, filing Form 4 there in the last year
Andrew R. BollPresident and CFO · President and CFO at Harrow, filing Form 4 there in the last year
Mark L. BaumChief Executive Officer · Chief Executive Officer at Harrow, filing Form 4 there in the last year